Skip to main content
TipRanks
Go Ultimate75% OFF

Apimeds Pharmaceuticals US, Inc. (APUS) Market Cap & Net Worth

31 Followers

Apimeds Pharmaceuticals US, Inc. Market Cap

Apimeds Pharmaceuticals US, Inc. has a market cap or net worth of $4.06M as of Nov 13, 2026. Its market cap has decrease by 88.42% in one year.

Market Cap
$4.06M
Enterprise Value
$10.20T
1-Year Change
-88.42%
Category
Micro (Under 300M)
Stock Price
$2.36

Market Cap Chart

0.0020.00M40.00M60.00MMar 25Mar 26
Market Cap History
Download to Excel
APUS market cap history
DateMarket Cap% Change
Nov 11, 20263.56M-12.27%
Nov 10, 20264.06M-0.37%
Nov 09, 20264.07M-0.18%
Nov 06, 20264.08M-0.92%
Nov 05, 20264.12M-6.51%
Nov 04, 20264.41M-1.68%
Nov 03, 20264.48M+2.77%
Nov 02, 20264.36M-3.99%
Oct 30, 20264.54M-6.23%
Oct 29, 20264.84M+4.56%
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.Formula: Market Cap = Stock Price * Shares Outstanding

Related Stocks

Related stocks
CompanyMarket Cap
APUS$4.06M
SNOA$5.46M
AYTU$19.67M
CPIX$79.41M
YCBD$4.30M
BFRI$13.78M